Name Net increased
positions
Increased positions Reduced positions Return since
30 Sep ‘16
226
13 33 20 43.8%
227
13 131 118 33%
228
13 46 33 62.4%
RCKT icon
229
Rocket Pharmaceuticals
RCKT
$400M
13 29 16 90.2%
230
13 26 13 61.4%
231
13 25 12 28.7%
232
13 20 7 89.1%
233
13 53 40 46.1%
234
13 47 34 59.5%
235
13 13 0 47.8%
LAB icon
236
Standard BioTools
LAB
$485M
13 34 21 84.1%
237
13 53 40 52.4%
238
13 44 31 86%
239
13 65 52 14.8%
240
13 45 32 15%
241
13 15 2 45.2%
242
13 24 11 56.4%
243
13 50 37 50.4%
244
13 55 42 78%
245
13 79 66 65.3%
246
13 18 5 29%
247
13 28 15 27.7%
248
13 98 85 29.5%
249
13 44 31 115%
250
13 47 34 40.6%